DalsnaFinance › Analyst accuracy › JPMorgan › KURA target
JPMorgan initiates Kura Oncology stock with overweight rating
JPMorgan has initiated coverage of Kura Oncology (NASDAQ: KURA) with an "overweight" rating and established a price target of $30.00
A fact about what JPMorgan published, as reported by Investing.com, not a recommendation from Dalsna Finance; JPMorgan is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.